Friday, December 29, 2017

Sanofi Dengue Vaccine: Dengvaxia Poses Serious Risk for Children

Sanofi Dengue Vaccine: Dengvaxia Poses Serious Risk for Children

This is a developing news story focusing on the corruption of industry-initiated government vaccination policies. The case involves Sanofi and the launching of its Dengvaxia vaccine in a massive school-based Dengvaxia vaccination campaign in 830,000 Philippino school children.
The New York Times has just published its report,   noting that: “public health experts are worried that the distrust could spill over to other vaccination programs.”
Full story here:
http://ahrp.org/sanofi-dengue-vaccine-dengvaxia-poses-serious-risk-for-children/

No comments: